Author:
Delrieu Julien,Vellas Bruno
Reference23 articles.
1. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework;Biomarkers definitions working group;Clin Pharmacol Ther,2001
2. Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer’s disease: the ALZHEMED (tramiprosate) experience;Saumier;J Nutr Health Aging,2009
3. Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial;Green;JAMA,2009
4. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mildto-moderate Alzheimer’s disease: a randomised, double-blind, placebocontrolled study;Doody;Lancet,2008
5. Disease-modifying trials in Alzheimer’s disease: a European task force consensus;Vellas;Lancet Neurol,2007
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献